Artificial oocyte activation (calcium ionophore)
Chemically triggering the egg to activate after ICSI.
Written by Fertility Decoded. Reviewed by D R, MS (OBG), FRM. Review date: 31 August 2026.
The verdict
Only for specific fertilisation-failure cases, not routine.
Who are these bodies?
- HFEA
- — UK fertility regulator; rates add-ons by evidence (traffic-light).
- ESHRE
- — European fertility society; evidence-based practice guidance.
- NICE
- — UK health-guidance body; what the NHS will and won't fund.
- ISAR
- — Indian Society for Assisted Reproduction; Indian expert consensus.
- Cochrane
- — Independent global reviewers of the underlying studies.
HFEA
UK regulator
Not on HFEA's rated list — chance of a babySourceESHRE
European society
Recommended (fertilisation-failure group)Recommended for the relevant patient group (fertilisation failure, <30% fertilisation, or some severe male infertility).
SourceNICE
UK NHS guidance
Not addressedNot addressed in NG257.
ISAR
Indian society
Fertilisation-failure cases onlyFor oocyte-activation deficiency / previous fertilisation failure only; explicitly not beneficial for all; safety (cytotoxic/teratogenic/epigenetic) not fully established.
SourceCochrane
Evidence base
No Cochrane review identified specifically for this add-on.
Typical cost in India
Charged as a lab add-on; varies.
Sources
Take this further
Sources last reviewed .